1. Home
  2. PBF vs RYTM Comparison

PBF vs RYTM Comparison

Compare PBF & RYTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PBF Energy Inc.

PBF

PBF Energy Inc.

HOLD

Current Price

$26.52

Market Cap

3.5B

Sector

Energy

ML Signal

HOLD

Logo Rhythm Pharmaceuticals Inc.

RYTM

Rhythm Pharmaceuticals Inc.

HOLD

Current Price

$112.27

Market Cap

6.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PBF
RYTM
Founded
2008
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Integrated oil Companies
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.5B
6.4B
IPO Year
2012
2017

Fundamental Metrics

Financial Performance
Metric
PBF
RYTM
Price
$26.52
$112.27
Analyst Decision
Hold
Strong Buy
Analyst Count
11
13
Target Price
$30.64
$128.31
AVG Volume (30 Days)
2.6M
976.4K
Earning Date
02-12-2026
11-04-2025
Dividend Yield
4.15%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$29,544,100,000.00
$174,334,000.00
Revenue This Year
N/A
$47.34
Revenue Next Year
$3.13
$55.95
P/E Ratio
N/A
N/A
Revenue Growth
N/A
54.92
52 Week Low
$13.62
$45.91
52 Week High
$41.48
$122.20

Technical Indicators

Market Signals
Indicator
PBF
RYTM
Relative Strength Index (RSI) 27.62 57.11
Support Level $25.90 $110.30
Resistance Level $27.20 $115.04
Average True Range (ATR) 1.34 4.93
MACD -0.47 0.28
Stochastic Oscillator 10.34 55.35

Price Performance

Historical Comparison
PBF
RYTM

About PBF PBF Energy Inc.

PBF Energy Inc is an independent petroleum refiner and supplier of unbranded transportation fuels, heating oil, petrochemical feedstocks, lubricants, and other petroleum products in the United States. The company owns refineries in Delaware, Ohio, New Jersey, California, and Louisiana. The Company operates in two reportable business segments: Refining and Logistics. The Company's oil refineries are all engaged in the refining of crude oil and other feedstocks into petroleum products and are aggregated into the Refining segment. PBFX operates logistics assets such as crude oil and refined products terminals, pipelines and storage facilities. The Logistics segment consists solely of PBFX's operations.

About RYTM Rhythm Pharmaceuticals Inc.

Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. It is engaged in the development and commercialization of therapies for patients with rare diseases. The company is focused on its melanocortin-4 receptor (MC4R) agonists, including its main asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. Geographically the company generates its revenue from the United States and internationally with the majority being generated from the United States.

Share on Social Networks: